Skip to content
Screener

Harmony Biosciences Holdings, Inc. HRMY Deferred Tax Assets and Other Non-Current Assets

Deferred Tax Assets and Other Non-Current Assets at other companies

Amneal Pharmaceuticals, Inc. logo
Amneal Pharmaceuticals, Inc.AMRX
$80.67M+79.9%
Acadia Pharmaceuticals logo
Acadia PharmaceuticalsACAD
$3.55M+57.6%
Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
$3K-98.6%
Praxis Precision Medicines, Inc. logo
Praxis Precision Medicines, Inc.PRAX
$643K
Jazz Pharmaceuticals logo
Jazz PharmaceuticalsJAZZ
Alkermes logo
AlkermesALKS

Other financials

Income statement

See full
Revenue$215.4M+16.6%
Gross profit$170.9M+11.9%
Operating income$37.3M-33.7%
Net income$32.5M-28.7%
EPS (diluted)$0.55-29.5%

Balance sheet

See full
Cash & equivalents$589.4M+20.5%
Total debt$164.6M-7.2%
Total equity$910.3M+26.3%
Total assets$1.3B+20.5%

Cash flow

See full
Operating cash flow$27.8M-18.3%
CapEx$107.0K-79.1%
Free cash flow$126.0M+67.9%

Valuation

See full
Market cap$2.24B+13.4%
Enterprise value$1.81B+13.3%
P/E15.4×+4.5×
P/S2.5×-0.1×

Profitability

See full
Gross margin76.5%-1.8pp
Operating margin21.1%-5.1pp
Net margin16.2%-4.3pp
FCF margin40.1%+9.5pp

Returns & leverage

See full
Return on equity17.9%-6.9pp
Debt / equity0.2×-0.1×
Current ratio3.6×-0.1×

Where this comes from

Reported directly by Harmony Biosciences Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.

The source filing: Harmony Biosciences Holdings, Inc.’s 10-Q, filed May 7, 2026.

Filed
May 7, 2026, 8:16 AM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001104659-26-056720
Line itemMarch 31, 2026December 31, 2025
Investments, long-term229,555107,127
Intangible assets, net83,45789,418
Deferred tax asset153,562149,699
Other noncurrent assets26,43318,373
Total noncurrent assets493,007364,617
TOTAL ASSETS$1,271,824$1,271,631
LIABILITIES AND STOCKHOLDERS’ EQUITY
CURRENT LIABILITIES:

Item 1. Financial Statements

FAQ

What is Harmony Biosciences Holdings, Inc.'s deferred tax assets and other non-current assets?
Harmony Biosciences Holdings, Inc. (HRMY) reported deferred tax assets and other non-current assets of $26.43M in Q1 2026.
How has Harmony Biosciences Holdings, Inc.'s deferred tax assets and other non-current assets changed year-over-year?
Harmony Biosciences Holdings, Inc.'s deferred tax assets and other non-current assets increased by 345.1% year-over-year, from $5.94M to $26.43M.
What is the long-term trend for Harmony Biosciences Holdings, Inc.'s deferred tax assets and other non-current assets?
Over 5 years (2020 to 2025), Harmony Biosciences Holdings, Inc.'s deferred tax assets and other non-current assets has grown at a 160.9% compound annual growth rate (CAGR), from $152K to $18.37M.

Ask your AI about Harmony Biosciences Holdings, Inc.'s deferred tax assets and other non-current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude